{
    "URL": "https://doi.org/10.1371/journal.pntd.0007912",
    "Published": "January 6, 2020",
    "Subject_Areas": [
        "Enzyme-linked immunoassays",
        "Antibodies",
        "Conjugate vaccines",
        "Vaccines",
        "Typhoid",
        "Vaccine development",
        "Fevers",
        "Antigens"
    ],
    "Authors": {
        "Robert T. Cartee": [
            "Matrivax Research & Development Corporation, Boston, MA, United States of America"
        ],
        "Ann Thanawastien": [
            "Matrivax Research & Development Corporation, Boston, MA, United States of America"
        ],
        "Thomas J. Griffin IV": [
            "Matrivax Research & Development Corporation, Boston, MA, United States of America"
        ],
        "John J. Mekalanos": [
            "Department of Microbiology, Harvard Medical School, Boston MA, United States of America"
        ],
        "Stephan Bart": [
            "Trial Professionals Consulting Group Inc., Woodstock, MD, United States of America"
        ],
        "Kevin P. Killeen": [
            "Matrivax Research & Development Corporation, Boston, MA, United States of America"
        ]
    }
}